FDA has released finalized, nonbinding guidance on the characterization and qualification of cell substrates and biologicial materials used in the production of viral vaccines.
A critical section for manufacturers regards testing at different stages of production, from cell banks and pre-production cells to final filled product. The guidance also contains descriptions of test methods for adventitious agents and cell properties.
Click here to view.
